| ADNYX | FSMAX | ADNYX / FSMAX | |
| Total Expense Ratio | 1.14 | 0.04 | 3,257% |
| Annual Report Gross Expense Ratio | 1.25 | 0.04 | 3,571% |
| Fund Existence | 9 years | 15 years | - |
| Gain YTD | 5.933 | 15.427 | 38% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 166M | 42.7B | 0% |
| Annual Yield % from dividends | 0.00 | 0.50 | - |
| Returns for 1 year | 20.58 | 29.23 | 70% |
| Returns for 3 years | 94.59 | 73.83 | 128% |
| Returns for 5 years | -50.74 | 33.65 | -151% |
| Returns for 10 years | N/A | 153.47 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNSX | 78.27 | 1.43 | +1.86% |
| Janus Henderson Global Life Sciences S | |||
| ANPRX | 32.69 | N/A | N/A |
| Virtus NFJ Mid-Cap Value R6 | |||
| VESGX | 52.92 | N/A | N/A |
| Vanguard Global ESG Select Stk Admiral | |||
| LFGVX | 46.54 | N/A | N/A |
| Lord Abbett Focused Growth R6 | |||
| GFACX | 72.91 | -0.39 | -0.53% |
| American Funds Growth Fund of Amer C | |||